Evosep aims to improve quality of life and patient care by radically innovating how protein-based clinical diagnostics are performed. Through reliable, scalable, and standardized solutions, Evosep creates a strong foundation for translational proteomics – making both sample preparation and separation up to 10 times faster and 100 times more robust than today’s alternatives.

Whether studying a peptide in the lab, designing therapies informed by protein signals, or developing novel clinical trial endpoints, Evosep’s decades-deep proteomics expertise empowers customers to embrace the next wave of omics-driven innovation. Robust solutions seamlessly transition from research to the clinic, bringing the power of proteomics back to the patient.

From sample to insights, Evosep is transforming clinical proteomics from the ground up. By collaborating with world-leading scientists, we introduce innovative technologies and standardized workflows that ensure speed, reproducibility, and confidence at scale.

Proteomics, the study of proteins and their interactions, is key to understanding health and disease. In clinical proteomics, the goal is to quickly and accurately compare patient samples against panels of protein biomarkers to deliver reliable diagnoses. Achieving this at scale requires high-throughput sample processing, standardized protocols, and exceptionally robust consumables.

Clinical samples such as blood or biopsies are far more complex than the clean cell cultures used in basic research. That’s why Evosep focuses on creating standardized solutions for both sample preparation and separation – ensuring consistent, high-quality results for every step of the workflow.